UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

UiPath, Inc. (NYSE:PATH) is one of the 10 best low-priced AI stocks to buy now. As of March 4, 2026, analyst sentiment remains largely mixed, with UiPath, Inc. (NYSE:PATH) facing pressure amid a 15% ...

Specialty pharmacy organization recognized as one of the 25 most innovative UiPath customers leveraging agentic automation NEW PROVIDENCE, NJ, UNITED STATES, October ...

Automation has evolved. Where a decade ago we were happy (if not positively exhilarated) to talk about the application of intelligent document processing and robotic process automation as progressive ...

While conversational AI and agent-based assistants have demonstrated isolated value, scaling AI across the enterprise has remained elusive. Key blockers include security and compliance risks, lack of ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

UiPath Inc. (PATH) is one of a bunch of software companies that went public in 2021, saw its shares subsequently collapse, and have seemingly never managed to make a recovery. And to be fair, many of ...

UiPath announces agentic AI solutions for healthcare revenue cycle management at ViVE 2026, targeting medical records review, claim denials and prior authorization. The company argues that ...

UiPath (NYSE: PATH), a global leader in agentic automation, today announced new agentic AI solutions for the healthcare ...